NCT02751359View on ClinicalTrials.gov

Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

April 30, 2020

Conditions
Pain
Interventions
DRUG

Cannabidiol

200, 400, or 800 mg Cannabidiol

DRUG

Placebo

0 mg Cannabidiol

Trial Locations (1)

10013

Cooper, New York

Sponsors

Collaborators (1)

INSYS Therapeutics Inc
All Listed Sponsors
collaborator

INSYS Therapeutics Inc

INDUSTRY

lead

University of California, Los Angeles

OTHER